2013-02-21 21:25 ET - Prospectus Approved
This press release just came out (see below) . The key wording here is "WILL LIST an additional 8 million shares, which means the offering has already been fully subscribed. These shares WILL be listed on the 25th. Great to see that the interest was that strong!
Oncolytics Biotech Inc. will list an additional eight million shares on the Toronto Stock Exchange at the open on Monday, Feb. 25, 2013, according to the TSX. As in a Feb. 20, 2013, prospectus supplement, the company plans to sell eight million shares at $4 (U.S.) each, raising $32-million (U.S.). Oncolytics has granted the underwriters an overallotment option to buy up to 1.2 million more shares at the same price for 30 days from the closing of the offering. The company plans to use the money raised to finance a clinical trial program and a manufacturing program, and for general corporate and working capital purposes.
Wrong. If you look at the press release announcing the pricing of the shares, you'll see the following phrase. "The offering is expected to close on or about Feb. 25, 2013". That is/was they're "hoped for" date, which is why it says "on or about", depending on how the sale went. That the TSX has now said the shares WILL be listed on the 25th displays that they are now fully subscribed.